News

The Federal Trade Commission last week filed a suit accusing the three largest pharmacy benefit managers, or PBMs, of using their market...

The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin...

Prescription drug prices in the U.S. receive a lot of attention. Some of it is academic, such as comparisons amongst how we measure drug...

The American Medical Association (AMA) today published its new annual analysis (PDF) of pharmacy benefit manager (PBM) markets...

It is a safe bet that pharmacy benefit managers (PBMs) aren’t going to become a big issue in the presidential election. PBMs are still...

President Joe Biden, Vice President Kamala Harris, and U.S. Department of Health and Human Services Secretary Xavier Becerra have a...

As Congress investigates the pharmacy benefit manager (PBM) problem, these middlemen corporations continue steering patients away from...

The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings...

On the heels of the FTC’s investigation into pharmacy benefit managers for what many regard as anti-competitive business practices, legal...

Likely Voters Want Policies to Require PBM Middlemen to Provide Value, Lower Out-of-Pocket Prescription Drug Costs Washington, DC – On...

Pharmacy middlemen known as pharmacy benefit managers deny claims that they’re responsible for the inflating cost of medicine. They say...

On Wednesday, July 9, the National Community Pharmacists Association (NCPA) and Coalition of State Rheumatology Organizations (CSRO) –...

The hearing keeps attention on PBM reforms as Congress nears the period between elections in November and when newly elected officials...

Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight...

The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...

In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing...

Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs...

In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in...

One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...

The New York Times has published a detailed investigation into how middlemen pharmacy benefit managers (PBMs) drive up drug costs for...

This is Part 2 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >

This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >

Imagine going to the doctor and being told you have a life-threatening condition that can only be treated with a daily dose of...